Home › Funds › Amova Asset Management Americas, Inc. › NTLA

Amova Asset Management Americas, Inc. position in NTLA

INTELLIA THERAPEUTICS INC · Health Care

Amova Asset Management Americas, Inc. reported holding 3,610,687 shares of NTLA (INTELLIA THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$43.5M, representing 0.54% of its reported portfolio and ranking #46 among its reported holdings. Amova Asset Management Americas, Inc. has disclosed NTLA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)3.61M sh
Reported value held$43.51M
Portfolio Weight0.54%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Amova Asset Management Americas, Inc.'s NTLA position evolved

Amova Asset Management Americas, Inc. first disclosed a stake in NTLA in Q3 2023 at 3,520,295 shares (US$111.2M). Across 13 filings, Amova Asset Management Americas, Inc. increased the stake 2 time(s), trimmed it 10 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 3,610,687 shares valued at US$43.5M — an increase of 713,158 shares quarter over quarter.. Notable position changes include a 47% increase in Q2 2026 (shares fell 29% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 3.52M $111.17M New
Q4 2023 3.48M $105.96M Reduce
Q1 2024 3.40M $93.38M Reduce
Q2 2024 3.26M $72.91M Reduce
Q3 2024 3.15M $64.67M Reduce
Q4 2024 2.99M $34.89M Reduce
Q1 2025 2.83M $20.00M Reduce
Q2 2025 2.67M $25.00M Reduce
Q3 2025 2.35M $40.62M Reduce
Q4 2025 2.19M $19.69M Reduce
Q1 2026 1.97M $25.27M Reduce
Q2 2026 2.90M $49.03M Add
Q3 2026 3.61M $43.51M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About NTLA and 13F data

NTLA (INTELLIA THERAPEUTICS INC) is a Health Care company. 33 other funds we track also report a position in NTLA — the largest reported positions include ARK Invest (US$192.1M), RA CAPITAL MANAGEMENT, L.P. (US$76.6M), REGENERON PHARMACEUTICALS, INC. (US$44.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding NTLA

All NTLA fund holders →

FAQ

How long has Amova Asset Management Americas, Inc. held NTLA?

Amova Asset Management Americas, Inc. has disclosed NTLA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Amova Asset Management Americas, Inc.'s current position in NTLA?

As of Q3 2026, Amova Asset Management Americas, Inc. holds 3.61M shares of NTLA (INTELLIA THERAPEUTICS INC), valued at $43.51M, representing 0.54% of its reported portfolio and ranking #46.

Has Amova Asset Management Americas, Inc. been buying or selling NTLA?

In the latest 13F filing (Q3 2026), Amova Asset Management Americas, Inc. increased its position in NTLA.

Which other funds hold NTLA?

Other major institutional holders of NTLA include ARK Invest, RA CAPITAL MANAGEMENT, L.P., REGENERON PHARMACEUTICALS, INC., among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.